Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Max Miller Wattenberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8120-1132; OpenAlex author ID A5052816083; NIH RePORTER profile ID 15580601. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
1
Labs led
2
Collaborators
26
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper, 1 grant

Papers 7

  1. Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer. First author DOI 10.1038/s41598-026-35423-7↗
  2. Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2024.01.013↗
  3. Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. First author DOI 10.1038/s41467-023-41771-z↗
  4. Systemic inflammation is a determinant of outcomes of CD40 agonist-based therapy in pancreatic cancer patients. Co-author DOI 10.1172/jci.insight.145389↗
  5. Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, B… Co-author DOI 10.1200/jco.21.00003↗
  6. Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. Co-author DOI 10.3390/cancers13184716↗
  7. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. Co-author DOI 10.1038/s41416-019-0582-7↗

Grants 1

  1. Investigating CD4+ T cell memory in cancer immunotherapy K08CA277009↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gregory Lawrence Beatty · 6 shared papers, 2020–2026 · strength 0.96
  2. Kim A. Reiss · 4 shared papers, 2020–2026 · strength 0.76
  3. Robert H. Vonderheide · 2 shared papers, 2021–2026 · strength 0.37
  4. John C. McVey · 1 shared paper, 2026 · strength 0.26
  5. Ben Z. Stanger · 1 shared paper, 2026 · strength 0.26
  6. Susan M. Domchek · 2 shared papers, 2020–2021 · strength 0.22
  7. Katherine L. Nathanson · 2 shared papers, 2020–2021 · strength 0.22
  8. Davendra P. S. Sohal · 1 shared paper, 2024 · strength 0.17
  9. Kajsa E. Affolter · 1 shared paper, 2024 · strength 0.17
  10. Muhammad Shaalan Beg · 1 shared paper, 2024 · strength 0.17
  11. Syed Arif Ahmad · 1 shared paper, 2024 · strength 0.17
  12. Sean J. Mulvihill · 1 shared paper, 2024 · strength 0.17
  13. Andrew M. Lowy · 1 shared paper, 2024 · strength 0.17
  14. Andrea Wang‐Gillam · 1 shared paper, 2024 · strength 0.17
  15. Ignacio Garrido‐Laguna · 1 shared paper, 2024 · strength 0.17
  16. Philip A. Philip · 1 shared paper, 2024 · strength 0.17
  17. Elena Gabriela Chiorean · 1 shared paper, 2024 · strength 0.17
  18. Erica L. Carpenter · 1 shared paper, 2021 · strength 0.16
  19. Stacy K. Thomas · 1 shared paper, 2023 · strength 0.15
  20. Meredith L. Stone · 1 shared paper, 2023 · strength 0.15
  21. Peter James O'Dwyer · 1 shared paper, 2020 · strength 0.11
  22. Mark Alan Rosen · 1 shared paper, 2020 · strength 0.11
  23. Shun Yu · 1 shared paper, 2020 · strength 0.11
  24. Thomas Benjamin Karasic · 1 shared paper, 2021 · strength 0.11
  25. Zain M. Hannan · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.